Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

We recently compiled a list of the Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders.

Not always. Some companies with exceptionally high dividend yields can easily afford to keep the dividends flowing. Pfizer (NYSE: PFE) is in that group, in my opinion. The big drugmaker's forward ...

Dividend stocks have long been favored by investors for the income they generate, and they become even more appealing when ...